Market Overview:
The global alpha-1 proteinase inhibitor market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic obstructive pulmonary disease (COPD) and other respiratory disorders, rising geriatric population, and technological advancements in the field of alpha-1 proteinase inhibitors. Based on type, the global alpha-1 proteinase inhibitor market is segmented into solution and powder. The solution segment is expected to account for a larger share of the market than the powder segment during the forecast period. This can be attributed to factors such as ease of use and higher efficacy offered by solutions as compared to powders. Based on application, the global alpha-1 proteinase inhibitor market is divided into hospital and clinic settings. The hospital setting segment is anticipated to hold a larger share of this market during 2018–2030 owing mainly due high incidence rate COPD patients across globe . However, with increasing preference for home care over hospitalization among patients suffering from chronic diseases such as COPD will restrain growth rate Hospital Setting Segment During Forecast Period . On basis regional presence , North America dominates Global Alpha - 1 Proteinase Inhibitor Market with highest revenue contribution followed by Europe & Asia Pacific region respectively while MEA region accounts lowest revenue contribution throughout forecast period .
Product Definition:
Alpha-1 Proteinase Inhibitor is a protein that is produced by the body to inhibit the activity of alpha-1 proteinase. Alpha-1 proteinase is responsible for breaking down proteins in the body, so inhibiting its activity can help to preserve proteins. Alpha-1 Proteinase Inhibitor can be used as a treatment for diseases that involve too much breakdown of proteins, such as emphysema and cystic fibrosis.
Solution:
Solution is a chemical compound which has the ability to inhibit the action of alpha-1 proteinase inhibitor. Solution can be used as an alternative for Alpha-1 Proteinase Inhibitor and can also be utilized in combination with it. It is also known as anticoagulant solution or coagulation factor solution, which contains citric acid and sodium bicarbonate (NaHCO3).
Powder:
Powder is a dry solid form of the product which can be easily handled and stored. It helps in reducing the overall cost of manufacturing process due to its easy handling and storage capability. Powder also allows for ease in incorporating various additives such as starch, bromelain, magnesium trisilicate among others during processing which results into improved quality characteristics such as thermal stability, flow behavior & particle size among others.
Application Insights:
The market is segmented based on the application of alpha-1 proteinase inhibitor, namely hospital, clinic and others. The hospital segment dominated the market in 2017 due to increasing prevalence of chronic diseases such as cancer and diabetes that require regular medical checkups. In addition, rising awareness about these products among healthcare professionals is expected to drive demand over the forecast period.
Alpha-1 proteinase inhibitors are used for treating various conditions related to wound healing such as diabetic foot ulcers, pressure ulcers and venous leg ulcers among others. Increasing cases of chronic diseases across the globe are anticipated to boost product demand in clinics over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement scenario and increasing prevalence of cancer & diabetes are some major factors responsible for its growth. Moreover, growing awareness about proteinase inhibitors among healthcare professionals and patients is expected to propel the regional demand over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income coupled with improving healthcare infrastructure in emerging countries such as China & India. Furthermore, an increase in research funding by public agencies will boost product development activities thereby driving market growth over the next eight years.
Growth Factors:
- Increasing prevalence of respiratory diseases: The increasing prevalence of respiratory diseases is one of the major growth drivers for the Alpha-1 Proteinase Inhibitor market. According to the World Health Organization, around 235 million people were suffering from asthma in 2015, and this number is expected to reach 300 million by 2025. This will create a high demand for Alpha-1 Proteinase Inhibitors as they are used for the treatment of respiratory diseases.
- Growing awareness aboutAlpha-1 Proteinase Inhibitors: There is a growing awareness aboutAlpha-1 Proteinase Inhibitors among patients and healthcare professionals due to their efficacy in treating various respiratory disorders. This is likely to boost the demand forAlpha-1 Proteinase inhibitors in the coming years.
- Technological advancements: The development of novel technologies has led to the introduction of new and improved products in the Alpha- 1Proteinase inhibitor market, thereby driving its growth. For instance, Gilead Sciences has developed an oral formulationof its drug Soliris (eculizumab) which can be administered once a week insteadof every other day as required withthe intravenous formulationand this could lead topromote wider useofSolirisin future clinical practice settings .This will provide impetusto th egrowthofthe Alpha - 1Proteinas eInh ibitormarket .
Scope Of The Report
Report Attributes
Report Details
Report Title
Alpha-1 Proteinase Inhibitor Market Research Report
By Type
Solution, Powder
By Application
Hospital, Clinic
By Companies
Takeda, Kamada, Grifols, CSL Behring
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
143
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Alpha-1 Proteinase Inhibitor Market Report Segments:
The global Alpha-1 Proteinase Inhibitor market is segmented on the basis of:
Types
Solution, Powder
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Takeda
- Kamada
- Grifols
- CSL Behring
Highlights of The Alpha-1 Proteinase Inhibitor Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Solution
- Powder
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Alpha-1 Proteinase Inhibitor Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Alpha-1 proteinase inhibitor is a medication used to treat various types of arthritis. It works by blocking the activity of alpha-1 proteinases, which are enzymes that can damage cartilage and other tissues in the body.
Some of the major players in the alpha-1 proteinase inhibitor market are Takeda, Kamada, Grifols, CSL Behring.
The alpha-1 proteinase inhibitor market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Alpha-1 Proteinase Inhibitor Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Alpha-1 Proteinase Inhibitor Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Alpha-1 Proteinase Inhibitor Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Alpha-1 Proteinase Inhibitor Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Alpha-1 Proteinase Inhibitor Market Size & Forecast, 2020-2028
4.5.1 Alpha-1 Proteinase Inhibitor Market Size and Y-o-Y Growth
4.5.2 Alpha-1 Proteinase Inhibitor Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Solution
5.2.2 Powder
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Alpha-1 Proteinase Inhibitor Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Alpha-1 Proteinase Inhibitor Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Solution
9.6.2 Powder
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Solution
10.6.2 Powder
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Solution
11.6.2 Powder
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Solution
12.6.2 Powder
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Solution
13.6.2 Powder
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Alpha-1 Proteinase Inhibitor Market: Competitive Dashboard
14.2 Global Alpha-1 Proteinase Inhibitor Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Takeda
14.3.2 Kamada
14.3.3 Grifols
14.3.4 CSL Behring
